News

"Would make a huge difference in a production system." Researchers make revolutionary breakthrough to protect crucial food ...
The non-coding genome, once dismissed as "junk DNA", is now recognized as a fundamental regulator of gene expression and a ...
The global Live Cell RNA Detection Market is set for robust expansion, with valuation projected to rise from USD 3.4 billion ...
A new study suggests an enzyme unique to Homo sapiens may have made us more competitive water seekers than our closest ...
Dawnzera is the first and so far only RNA-targeting therapy approved as a prophylactic treatment for hereditary angioedema ...
Merck KGaA agreed to a deal with RNA biotech Skyhawk Therapeutics that could top out at $2 billion. Roche’s Genentech terminated a cell therapy partnership with Adaptive Biotechnologies, ending what ...
In the wake of funding cuts to mRNA vaccine research, we revisit a February story about a promising vaccine for pancreatic ...
For leaders in business, failing to learn the lessons of a crisis can be disastrous. For leaders in government, when millions ...
"I am saddened and outraged that more citizens are not tuning into this war against scientific health research in the United ...
In June, the monoclonal antibody garadacimab (Andembry) was approved for prevention of HAE attacks at a dose of once monthly ...